Sitagliptin Tartrate Hemihydrate is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus to help regulate blood glucose levels. This pharmaceutical reference standard… Read more
Sitagliptin Tartrate Hemihydrate is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus to help regulate blood glucose levels. This pharmaceutical reference standard supports rigorous quality control and analytical assessment during the manufacturing of the active pharmaceutical ingredient. Laboratories rely on a comprehensive range of related compounds, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled versions, to ensure accuracy in regulatory testing environments. These materials are essential for effective impurity profiling, enabling the precise identification and quantification of degradants and trace contaminants. Furthermore, they are critical for method validation and bioanalytical studies, particularly when utilizing techniques such as HPLC-MS/MS. By providing highly characterized materials, these standards assist researchers in maintaining data integrity, calibrating analytical instrumentation, and verifying the potency and identity of drug substances throughout both drug development and routine batch release testing.